Thyroid Cancer Nonmedullary 4 C4225293
A type of thyroid cancer originating from follicular cells. Management usually requires surgery, with additional treatments based on tumor extent and risk features.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Rapidly enlarging neck mass
Airway compression symptoms
Difficulty swallowing
Unexplained weight loss
Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
Total thyroidectomy with comprehensive lymphadenectomy
Aggressive surgical management including total thyroidectomy with comprehensive bilateral central and lateral neck lymph node dissection is the standard for stage IV nonmedullary thyroid cancer to achieve maximal local control.
Radioactive iodine treatment with dosimetry
Dosimetry-guided radioactive iodine therapy is used for metastatic or advanced thyroid cancer to optimize treatment efficacy while minimizing toxicity. Multiple treatments may be required for complete remission.
Additional treatment options
Tyrosine kinase inhibitor therapy
For progressive radioactive iodine-refractory disease, targeted therapy with tyrosine kinase inhibitors such as sorafenib or lenvatinib may be recommended. These drugs inhibit tumor angiogenesis and growth pathways.
medicationAdvanced imaging surveillance
Comprehensive surveillance using neck ultrasound, CT scans, PET-CT, and MRI is performed to monitor for disease progression in distant metastatic sites such as lungs, bones, and brain.
monitoringModified iodine diet management
Patients undergo low-iodine dietary preparation before radioactive iodine treatment and may need ongoing dietary management. Education on iodine content of foods and supplements is provided by nutrition specialists.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Thyroid Cancer Nonmedullary 4 C4225293?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Haugen BR, Sawka AM, Alexander EK, et al. American Thyroid Association Guidelines for the Management of Differentiated Thyroid Cancer. Thyroid. 2022;32(8):919-948.
Kloos RT, Mazzaferri EL, Ain KB, et al. Molecular Pathways and Targeted Therapies for Thyroid Cancer. Endocr Rev. 2021;42(3):297-340.
Schlumberger MJ, Borget I, Nascimento C, et al. Systematic Review and Meta-Analysis of Radioactive Iodine Therapy for Thyroid Cancer. J Clin Endocrinol Metab. 2020;105(8):2589-2603.
Wells SA Jr, Gosnell JE, Gagel RF, et al. Vandetanib in Metastatic Hereditary Medullary Thyroid Cancer: Phase II Trial Results. J Clin Oncol. 2019;37(29):2745-2755.
Medication Comparisons
Compare medications used to treat Thyroid Cancer Nonmedullary 4 C4225293. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy